Меню
Набор скоро начнётся NCT07466537

Efficacy and Safety of Intravaginal EMS Treatments in Women With Exclusive or Predominant Stress Urinary Incontinence

Без фазы С лечением Stress Urinary Incontinence (SUI)

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Electrical intravaginal muscle stimulation.
Кому может быть актуально
Состояния в реестре: Stress Urinary Incontinence (SUI). Базовые параметры: от 18 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Список центров уточняется — проверьте первичный протокол.
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Efficacy and Safety of 6 Intravaginal EMS Treatments in Women With Exclusive or Predominant Stress Urinary Incontinence

Обзор

The investigator wants to evaluate the efficacy of a specific intravaginal Electrical Muscle Stimulation (EMS), in the treatment of exclusive or predominant stress urinary incontinence (SUI) symptoms in women. The investigator's aim is to determine the device's impact (the device is VTone) on reducing urinary incontinence episodes and on improving women's quality of life.

Вмешательства

  • Устройство Electrical intravaginal muscle stimulation
    The device includes an ogival, circular body, with a handle at one end of the body, a head at the other end of the body. The head includes a substantially flat, metallic surface. The device and the head are sized and configured to be received in a patient's vagina. The device should be used with gel. Patients will be trated with six sessions (planned once a week for a total of six week).

Первичные конечные точки

  • Variation in patient bladder voiding diaries' results at follow up visits versus baseline [Срок оценки: Follow up visits: 1 month and 3 months after the last session of treatment]

Критерии участия

Критерии включения

  • Women with minimum age of 18 years .
  • Documented clinical diagnosis of exclusive or predominant stress urinary incontinence.
  • Willingness to comply with study procedures and follow-up visits.
  • Signed informed consent to participate in the study.
  • BMI </= 30.

Критерии исключения

  • Pacemaker or internal defibrillator, or any other metallic or electronic implant anywhere in the body.
  • Any permanent implant or an injected chemical substance in the treatment area.
  • Superficial areas that have been injected with hyaluronic acid (HA)/collagen/fat injections or other augmentation methods with bio-material during last 6 months.
  • Current or history of cancer, or current condition of any other type of cancer, or premalignant moles.
  • Severe concurrent conditions, such as cardiac disorders, sensory disturbances, epilepsy, uncontrolled hypertension, and liver or kidney diseases.
  • Pregnancy
  • Impaired immune system due to immunosuppressive diseases such as AIDS and HIV or use of immunosuppressive medications.
  • Patients with a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only following a prophylactic regimen.
  • Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction and hormonal virilization.
  • Any active condition in the treatment area, such as sores, eczema, and rash.
  • History of bleeding coagulopathies or use of anticoagulants in the last 10 days, as per the practitioner's discretion.
  • Non-Italian speakers
  • Severely impaired mobility or cognition
  • Spinal cord injury or advanced/severe neurologic condition including Multiple Sclerosis, Parkinson's Disease
  • Repair of pelvic organ prolapse or incontinence procedure in the previous 6 months
  • Ongoing complications of prior anti-incontinence surgery
  • Received intravesical botulinum injection within the previous 12 months
  • History of an implanted nerve stimulator for incontinence
  • History of prior sling or vaginal mesh placement
  • Previous diagnosis of interstitial cystitis, bladder cancer, or chronic pelvic pain
  • Current participation in any other conflicting interventional or treatment study
  • Active urinary tract or vaginal infection
  • Current hydronephrosis or hydroureter
  • Bladder outflow obstruction
  • Active pelvic organ malignancy
  • Urethral obstruction
  • Urinary retention or prolonged catheter use
  • Less than 12 months post-partum
  • Untreated symptomatic urinary tract infection
  • Unevaluated hematuria
  • Not available for follow-up in 6 months
  • Participation in other research trials that could influence results of this study

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Лечение

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Идентификаторы

NCT: NCT07466537 · STONE

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗